Logo image of CBAT

CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

USA - NASDAQ:CBAT - US14986C1027 - Common Stock

0.95 USD
-0.03 (-3.06%)
Last: 10/21/2025, 10:18:39 AM
Fundamental Rating

3

CBAT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 92 industry peers in the Electrical Equipment industry. CBAT has a bad profitability rating. Also its financial health evaluation is rather negative. CBAT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CBAT had negative earnings in the past year.
CBAT had a positive operating cash flow in the past year.
In multiple years CBAT reported negative net income over the last 5 years.
In multiple years CBAT reported negative operating cash flow during the last 5 years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of CBAT (-2.75%) is better than 63.04% of its industry peers.
CBAT has a better Return On Equity (-7.74%) than 63.04% of its industry peers.
Industry RankSector Rank
ROA -2.75%
ROE -7.74%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

CBAT's Profit Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 17.22%, CBAT is doing worse than 61.96% of the companies in the same industry.
In the last couple of years the Gross Margin of CBAT has grown nicely.
The Profit Margin and Operating Margin are not available for CBAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

3

2. Health

2.1 Basic Checks

CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
CBAT has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CBAT has more shares outstanding
The debt/assets ratio for CBAT has been reduced compared to a year ago.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.13, we must say that CBAT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CBAT (-0.13) is comparable to the rest of the industry.
The Debt to FCF ratio of CBAT is 17.02, which is on the high side as it means it would take CBAT, 17.02 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 17.02, CBAT is doing good in the industry, outperforming 66.30% of the companies in the same industry.
A Debt/Equity ratio of 0.33 indicates that CBAT is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.33, CBAT perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 17.02
Altman-Z -0.13
ROIC/WACCN/A
WACC5.88%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.72 indicates that CBAT may have some problems paying its short term obligations.
CBAT has a Current ratio of 0.72. This is amonst the worse of the industry: CBAT underperforms 82.61% of its industry peers.
A Quick Ratio of 0.53 indicates that CBAT may have some problems paying its short term obligations.
CBAT's Quick ratio of 0.53 is on the low side compared to the rest of the industry. CBAT is outperformed by 79.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.53
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The earnings per share for CBAT have decreased strongly by -158.82% in the last year.
The earnings per share for CBAT have been decreasing by -42.83% on average. This is quite bad
CBAT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.70%.
The Revenue has been growing by 51.40% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-158.82%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-142.86%
Revenue 1Y (TTM)-35.7%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-15.21%

3.2 Future

Based on estimates for the next years, CBAT will show a very negative growth in Earnings Per Share. The EPS will decrease by -20.77% on average per year.
CBAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.65% yearly.
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-22.1%
Revenue Next 2Y11.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.1 -0.1

3

4. Valuation

4.1 Price/Earnings Ratio

CBAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 11.64, which indicates a very decent valuation of CBAT.
92.39% of the companies in the same industry are more expensive than CBAT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, CBAT is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 11.64
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CBAT is valued a bit cheaper than the industry average as 76.09% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 36.67
EV/EBITDA N/A
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A cheap valuation may be justified as CBAT's earnings are expected to decrease with -20.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CBAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (10/21/2025, 10:18:39 AM)

0.95

-0.03 (-3.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-18 2025-08-18/bmo
Earnings (Next)11-07 2025-11-07/bmo
Inst Owners2.19%
Inst Owner Change0%
Ins Owners25.81%
Ins Owner Change0%
Market Cap84.22M
Analysts0
Price Target1.53 (61.05%)
Short Float %1.2%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.97%
Min Revenue beat(2)-34.33%
Max Revenue beat(2)18.4%
Revenue beat(4)1
Avg Revenue beat(4)-22.71%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)18.4%
Revenue beat(8)2
Avg Revenue beat(8)-15.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.64
P/S 0.58
P/FCF 36.67
P/OCF 2.52
P/B 0.71
P/tB 0.71
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)0.08
Fwd EY8.59%
FCF(TTM)0.03
FCFY2.73%
OCF(TTM)0.38
OCFY39.73%
SpS1.64
BVpS1.33
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.75%
ROE -7.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.22%
FCFM 1.58%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 17.02
Debt/EBITDA N/A
Cap/Depr 425.27%
Cap/Sales 21.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.53
Altman-Z -0.13
F-Score2
WACC5.88%
ROIC/WACCN/A
Cap/Depr(3y)245.38%
Cap/Depr(5y)296.85%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-158.82%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-142.86%
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.7%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-15.21%
Revenue Next Year-22.1%
Revenue Next 2Y11.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-128.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y118.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y146.05%
OCF growth 3YN/A
OCF growth 5YN/A